Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL - Get Free Report)'s share price was down 5.5% during trading on Thursday . The company traded as low as $1.55 and last traded at $1.55. Approximately 1,683 shares were traded during trading, a decline of 86% from the average daily volume of 12,207 shares. The stock had previously closed at $1.64.
Wall Street Analyst Weigh In
Separately, HC Wainwright cut Adlai Nortye from a "buy" rating to a "neutral" rating in a research report on Monday, June 2nd.
Check Out Our Latest Research Report on ANL
Adlai Nortye Trading Down 5.5%
The stock's fifty day moving average is $1.78 and its two-hundred day moving average is $2.03. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 0.02.
Adlai Nortye Company Profile
(
Get Free Report)
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Adlai Nortye, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adlai Nortye wasn't on the list.
While Adlai Nortye currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
